MarketLens

Why is Johnson & Johnson Selling its Orthopedics Unit

6 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is Johnson & Johnson's $1 Billion Cell Therapy Investment a Game Changer

6 months ago

Johnson & Johnson's "New Era" of Growth: Why the Market Underestimates Its Innovative Pipeline

2 months ago

What's Driving Johnson Controls' Recent Momentum Ahead of Q2 Earnings

4 months ago

What Does Honeywell's Amended Deal for Johnson Matthey's Catalyst Business Signify

6 months ago

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future

Johnson & Johnson signaled that new drugs could offset declining sales from patent-protection losses, an 11-word message to shareholders about its future growth strategy.

JNJ

Stock News•4 weeks ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Johnson & Johnson won FDA approval for its Ottava surgical robot after years and hundreds of millions in investment, entering a market dominated by earlier competitors. Its challenge hinges on differe...

JNJ

Stock News•1 months ago

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

J&J's MedTech growth slowed in Q2, with Cardiovascular lagging. New product launches and stronger Vision, Surgery and Orthopedics could lift H2 sales.

JNJ

Breaking News

Event-Driven Investing

Healthcare

M&A

Robotics

Supply Chain Resilience

Top Headlines

View More →

Stock News•1 hour ago

Elon Musk Is Spending $119 Billion on A Single Building Outside Houston. Here's Who Actually Profits.

Stock News•2 hours ago

Dow Falls On News Of U.S.-Iran Attacks; Apple Slides

Stock News•2 hours ago

Amazon accused in new suit filed by FTC and 22 states of rigging ad auctions to inflate prices

Stock News•3 hours ago

You Could Buy Nvidia for Its 106% Revenue Growth and 75% Gross Margin. But There's an Even Better Reason the AI Stock Has Room to Run.

Stock News•3 hours ago

Why is Johnson & Johnson Selling its Orthopedics Unit

Exclusive Content for Pro Members

Related Articles

Is Johnson & Johnson's $1 Billion Cell Therapy Investment a Game Changer

Johnson & Johnson's "New Era" of Growth: Why the Market Underestimates Its Innovative Pipeline

What's Driving Johnson Controls' Recent Momentum Ahead of Q2 Earnings

What Does Honeywell's Amended Deal for Johnson Matthey's Catalyst Business Signify

Category

You may also like

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Elon Musk Is Spending $119 Billion on A Single Building Outside Houston. Here's Who Actually Profits.

Dow Falls On News Of U.S.-Iran Attacks; Apple Slides

Amazon accused in new suit filed by FTC and 22 states of rigging ad auctions to inflate prices

You Could Buy Nvidia for Its 106% Revenue Growth and 75% Gross Margin. But There's an Even Better Reason the AI Stock Has Room to Run.

Tesla Stock Has Been on a Hot Streak Ahead of Big Event This Week